Does the audiovisual perception promotion (AVWF) as a supplementary treatment module of the inpatient multimodal psychosomatic complex treatment affect the symptoms of Hyperarousals and the subjective perception of stress, the quality of sleep and on the physiological level the heart rate variability?

Does the audiovisual perception promotion (AVWF) as a supplementary treatment module of the inpatient multimodal psychosomatic complex treatment affect the symptoms of Hyperarousals and the subjective perception of stress, the quality of sleep and on the physiological level the heart rate variability? - AVWF hyperarousal

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

DRKS

Registry ID

DRKS00012352

Enrollment

Registered

2023-03-09

Start date

2016-10-10

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

F43.1

Interventions

Group 1: Patients will be randomly assigned to the intervention or control group. Both groups receive multimodal inpatient psychosomatic treatment over a period of 6-8 weeks in the Clinic for Psychoso

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: existence of a declaration of consent for the evaluation of the basic documentation in research projects; All patients who, upon admission to the University Clinic for Psychosomatics and Psychotherapy, Giessen, suffer from PTSD (ICD 10: F43.1), a panic disorder (ICD 10: F41.0) or a depressive disorder (ICD 10: F33.1, F32 .1) and show increased arousal in the hyperarousal subscale of the "Impact of Event Scale" (IES-R-Ü) (cut-off value = 15.8). Previous studies had shown that the mean (and the standard deviation) in the healthy non-traumatized control group at :M (SD) was 6.9 (8.9). (For comparison: in the samples “victims of crime” and “sexual violence” the following mean values ??were obtained in the subscale overarousal (IES-R-Ü): M(SD) 14.7 (10.7); “sexual violence”: M (SD) 27.8 (6.0).

Exclusion criteria

Exclusion criteria: Hearing difficulties, cardiac arrhythmias, presence of a psychosis, organic brain disorders or acute suicidality, substance use. Missing declaration of consent for the evaluation of the basic documentation and the additional questionnaire (Regensburg Insomnia Scale, RIS), incomplete answers to the questionnaire.

Design outcomes

Primary

Measure	Time frame
Subscale hyperarousal in the Impact of Event Scale revised (IES-R-H) at measurement times: t0 (screening, admission) and t1 (pre-intervention) and t2 (post-intervention)	—

Secondary

Measure	Time frame
• Heart rate variability (HRV) / measurement times: t1 (pre-intervention) and t2 (post-intervention) • Regensburg Insomnia Scale (RIS) / measurement times: t1 (pre-intervention) and t2 (post-intervention) • Hospital Anxiety and Depression Scale (HADS)/ measurement times: t0 (admission) and t3 (discharge) • Global Complaint Index (GSI) of the Symptom Checklist-90 (SCL-90) / measurement times: t0 (admission) and t3 (discharge) • Experience of stress (PSQ-30) / measurement times: t0 (admission) and t3 (discharge)	—

Measure

Time frame

• Heart rate variability (HRV) / measurement times: t1 (pre-intervention) and t2 (post-intervention) • Regensburg Insomnia Scale (RIS) / measurement times: t1 (pre-intervention) and t2 (post-intervention) • Hospital Anxiety and Depression Scale (HADS)/ measurement times: t0 (admission) and t3 (discharge) • Global Complaint Index (GSI) of the Symptom Checklist-90 (SCL-90) / measurement times: t0 (admission) and t3 (discharge) • Experience of stress (PSQ-30) / measurement times: t0 (admission) and t3 (discharge)

—

Countries

Germany

Contacts

Public ContactSabine Hauptmann

Klinik für Psychosomatische Medizin und Psychotherapie, UKGM Gießen

Sabine.Hauptmann@psycho.med.uni-giessen.de0641 985 45602

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026